These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7639943)

  • 21. [Value of ultrasonic diagnosis of fetal malformations in the detection of chromosomal abnormalities].
    Galliano D; Paillet C; Body G; Pierre F; Pourcelot D; Moraine C
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):203-8. PubMed ID: 2071864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid karyotyping in fetuses with abnormal sonogram.
    Hsieh FJ; Hsu HC; Ko TM; Chang FM; Chen HY; Jean HH; Chuang SM
    Acta Obstet Gynecol Scand; 1988; 67(7):621-5. PubMed ID: 3073624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound diagnosis of fetal abnormalities and cytogenetic evaluation.
    van Zalen-Sprock MM; van Vugt JM; Karsdorp VH; Maas R; van Geijn HP
    Prenat Diagn; 1991 Aug; 11(8):655-60. PubMed ID: 1837358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of fetal blood sampling by cordocentesis in fetuses with single umbilical arteries.
    Abdel-Fattah SA; Bartha JL; Kyle PM; Denbow ML; Soothill PW
    Prenat Diagn; 2004 Aug; 24(8):605-8. PubMed ID: 15305346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Usefulness of ultrasonographic markers in chromosomal abnormalities].
    Rivera Muñoz JE; Leis Márquez MT; García-Cavazos RJ; Hernández Andrade EA; Guzmán Huerta ME; Rodríguez-Bosch MR
    Ginecol Obstet Mex; 1997 Sep; 65():394-9. PubMed ID: 9410812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of nuchal translucency thickening in the fetal chromosome abnormality screening].
    Sun LJ; Wang X; Wu QQ; Ruan Y; Yao L
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):819-23. PubMed ID: 24444557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical approach to prenatal diagnosis of chromosome abnormalities].
    Herlicoviez M
    Reprod Nutr Dev; 1990; Suppl 1():139s-145s. PubMed ID: 2206291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transabdominal chorionic villi and placental biopsy: rapid karyotyping in the 1st-3rd trimester of pregnancy].
    Hitschold T; Berle P
    Ultraschall Med; 1997 Jun; 18(3):134-8. PubMed ID: 9340740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fetal blood sampling and its complications related to the indications for fetal blood sampling.
    Anandakumar C; Annapoorna V; Chee WY; Chia D; Bongso A; Ratnam SS
    Aust N Z J Obstet Gynaecol; 1993 Aug; 33(3):259-61. PubMed ID: 8304887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prenatal chromosome analysis using the FISH technique allows fetal aneuploidy detection within a few hours].
    Steinborn A; Röddiger S; Born HJ; Baier P; Halberstadt E
    Z Geburtshilfe Neonatol; 1996; 200(5):186-90. PubMed ID: 9035828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prenatal diagnosis of heart defects and associated chromosomal aberrations].
    Chaoui R; Körner H; Bommer C; Göldner B; Bierlich A; Bollmann R
    Ultraschall Med; 1999 Oct; 20(5):177-84. PubMed ID: 10595385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cordocentesis: experience in 391 initial samples].
    Donner C; Simon P; Gosselin F; Vermeylen D; Avni F; Liesnard C; Vamos E; Cochaux P; Vassart G; Rodesch F
    Rev Med Brux; 1990 Jun; 11(6):217-22. PubMed ID: 2371468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fetal blood sampling for karyotype using echoguided puncture of the cord. Study of 103 pregnancies].
    Boulot P; Courtieu C; Lefort G; Deschamps F; Sarda P; Galand B; Mares P; Hedon B; Laffargue F; Viala JL
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(8):1007-15. PubMed ID: 2695568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of prenatally detected nonlethal fetal anomalies: is a karyotype of benefit?
    Brumfield CG; Davis RO; Hauth JC; Cosper P; Colvin EV; Finley SC
    Am J Perinatol; 1991 Jul; 8(4):255-8. PubMed ID: 1741869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype.
    Cha'ban FK; Van Splunder P; Los FJ; Wladimiroff JW
    Prenat Diagn; 1996 Jun; 16(6):537-41. PubMed ID: 8809895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasound findings before amniocentesis in selecting the method of analysing the sample.
    Kagan KO; Chitty LS; Cicero S; Eleftheriades M; Nicolaides KH
    Prenat Diagn; 2007 Jan; 27(1):34-9. PubMed ID: 17154228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal karyotyping using fetal blood obtained by cordocentesis: rapid and accurate results within 24 hours.
    Tharapel SA; Dev VG; Shulman LP; Tharapel AT
    Ann Genet; 1998; 41(2):69-72. PubMed ID: 9706335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Karyotyping of at risk fetuses by cordocentesis in advanced gestation.
    Kabra M; Saxena R; Chinnappan D; Sanders V; Deka D; Buckshee K; Verma IC
    Indian J Med Res; 1996 Nov; 104():288-91. PubMed ID: 8979519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.